Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Automotive Industry Today.
Press releases published on May 22, 2025

Dianthus Therapeutics Appoints Simon Read, Ph.D., to Board of Directors
Dr. Read brings >30 years of leadership and scientific expertise in the biopharmaceutical industry Previously served as CEO and Founder of Mariana Oncology until its acquisition by Novartis in 2024 and CSO of Ra Pharma until its acquisition by UCB in 2020 …

Senti Bio to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar
SOUTH SAN FRANCISCO, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio” or the “Company”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene …

Rapid7 to Participate in Upcoming Investor Conferences
BOSTON, May 22, 2025 (GLOBE NEWSWIRE) -- Rapid7, Inc. (NASDAQ: RPD), a leader in extended risk and threat detection, today announced that the company will be attending the following conferences: The William Blair 45th Annual Growth Stock Conference in …

Inotiv, Inc. to Present at Jefferies Global Healthcare Conference 2025
WEST LAFAYETTE, Ind., May 22, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models …

TELA Bio to Participate in the 2025 Jefferies Global Healthcare Conference
MALVERN, Pa., May 22, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will participate in the 2025 …

Cavco Industries Reports Fiscal 2025 Fourth Quarter and Year End Results
PHOENIX, May 22, 2025 (GLOBE NEWSWIRE) -- Cavco Industries, Inc. (Nasdaq: CVCO) today announced financial results for the fourth quarter and fiscal year ended March 29, 2025. Quarterly Highlights Net revenue of $508 million up 21% from $420 million in the …

Gyre Therapeutics Announces Proposed Underwritten Public Offering of Common Stock
SAN DIEGO, May 22, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biotechnology company focused on organ fibrosis, today announced that it has commenced an underwritten public offering of shares of its …

Immix Biopharma Announces Positive Results for NXC-201 at ASCO Oral Presentation, Enabling Pathway to Best-in-Class Therapy for relapsed/refractory AL Amyloidosis
Immix Biopharma today reported ASCO abstract results from its U.S. multi-center NEXICART-2 Phase 1/2 clinical trial of NXC-201 demonstrating strong efficacy and favorable safety. – NXC-201 demonstrated a complete response (CR) rate of 71% (5/7 patients) – …

Outlook Therapeutics® Announces Proposed Public Offering of Common Stock and Warrants
ISELIN, N.J., May 22, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced that it has commenced an …

Intchains Group Limited Reports First Quarter 2025 Unaudited Financial Results
Total revenues of US$18.2 million exceeds guidance, up 445.5% YoY Total ETH-based cryptocurrency units were approximately 7,023, up 23.2% QoQ Income from operations reach US$5.1 million, achieving turnaround from prior-year period SINGAPORE, May 22, 2025 ( …

Gyre Therapeutics’ Hydronidone Met the Primary Endpoint and Demonstrated Statistically Significant Fibrosis Regression in Pivotal Phase 3 Trial for the Treatment of CHB-associated Liver Fibrosis in China
Achieved statistically significant ≥1-stage fibrosis regression at Week 52 vs. placebo (52.85% vs. 29.84%, P=0.0002). Demonstrated favorable safety and tolerability profile: 4.88% serious adverse events vs. 6.45% for placebo; zero discontinuations due to …

Lakeland Fire + Safety to Attend the 6th Annual CEO Networking Event Hosted by Semco Capital
HUNTSVILLE, Ala., May 22, 2025 (GLOBE NEWSWIRE) -- Lakeland Industries, Inc. (“Lakeland Fire + Safety” or “Lakeland”) (NASDAQ: LAKE), a leading global manufacturer of protective clothing and apparel for industry, healthcare and first responders, today …

IPG Photonics Appoints Mira Sahney as Senior Vice President of Global Laser Systems
MARLBOROUGH, Mass., May 22, 2025 (GLOBE NEWSWIRE) -- IPG Photonics Corporation (NASDAQ: IPGP), the global leader in high-performance fiber lasers and laser systems, announced the appointment of Mira Sahney as Senior Vice President, Global Laser Systems. …

Skywork.ai Launches Globally, Introducing the World’s First DeepResearch-Powered Workspace Super Agents
Singapore , May 22, 2025 (GLOBE NEWSWIRE) -- In May 2025, Skywork.ai officially entered the global stage, launching the world’s first AI Office Suite powered by DeepResearch technology, with full support for both English and Japanese to enhance …

Pixalate Unveils Q1 2025 North America Ad Viewability Benchmarks: 67% Mobile App Viewability in US; Desktop Web Ad Viewability at 58% in Canada
London, May 22, 2025 (GLOBE NEWSWIRE) -- Pixalate, the leading global platform for ad fraud protection, privacy, and compliance analytics, today released the Q1 2025 North America Programmatic Ad Viewability Benchmarks for the United States (U.S.) and …

IMG Academy Announces Acquisition of College Recruiting Service SportsRecruits
BRADENTON, Fla., May 22, 2025 (GLOBE NEWSWIRE) -- IMG Academy, the world’s leading sports education brand, today announced the acquisition of SportsRecruits, a college sports recruiting service with specialized products for families, club and high school …

PESG Research Report: A Review of Silexion Therapeutics' Innovative KRAS-Driven Cancer Treatment
New York, May 22, 2025 (GLOBE NEWSWIRE) -- PESG Research today announced the release of a report examining Silexion Therapeutics, an innovative biotechnology company developing unique RNA interference (RNAi) therapies targeting KRAS-driven cancers. The …

Pixalate Unveils Q1 2025 EMEA Ad Viewability Benchmarks: 62% Mobile App Viewability in UK, France Was 66% on Desktop Web; Netherlands at 53% on Mobile Apps
London, May 22, 2025 (GLOBE NEWSWIRE) -- Pixalate, the leading global platform for ad fraud protection, privacy, and compliance analytics, today released the Q1 2025 EMEA Programmatic Ad Viewability Benchmarks for the United Kingdom (UK), France, Spain, …

Toll Brothers Apartment Living® and Canyon Partners Real Estate Announce the Grand Opening of Navona, a New Luxury Apartment Community in Mesa, Arizona
MESA, Ariz., May 22, 2025 (GLOBE NEWSWIRE) -- Toll Brothers Apartment Living®, the rental subsidiary of Toll Brothers, Inc. (NYSE: TOL), the nation's leading builder of luxury homes, in partnership with Canyon Partners Real Estate, announces the grand …

Toll Brothers Announces New Luxury Home Community Coming Soon to Scottsdale, Arizona
SCOTTSDALE, Ariz., May 22, 2025 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced its newest community, Toll Brothers at HighPoint, is coming soon to Scottsdale, Arizona. This exclusive gated …